- NLM Digital Collections - Helping adolescents with HIV adhere to HAARTPublication: [Rockville, MD?] : [HRSA], [1999]... 65 B.3.4 Therapeutic Options when Changing Antiretroviral Therapy..................67 APPENDIX B References ........................................................................................68 C Sample HAART Regimens .............................................................................69 C.1 Regimen # 1 ......................................................................................................69 C.2 Regimen # 2 ......................................................................................................70 D Contacts For The Adolescent Medicine HIV/AIDS Research Network (AMHARN) ......................................................................73 viii HELPING ADOLESCENTS ...
- ... of the diseases being treated in patients with HIV infection, because the standard of practice either has not been set, is changing rapidly, or varies appreciably between geographic ocales. D. Because the initial emphasis was on antiretroviral therapies, the ACTG effort in OIs trials did not ...
- ... to call. For PWA’s intolerant to or failing antiretroviral therapy. When ... REFERENCE AIDS/HIV TREATMENT DIRECTORY. January 15, 1993, Vol. 6° No. ...
- ... to achieve the results of the highly active antiretroviral | therapies. The 076 ... mandated for HIV-positive mothers and their infants. I worry about ...
- ... use of prophylaxis against Pneumocystis carinii pneumonia and ... pneumonia as their initial diagnosis decreased from 62 percent in 1988 to ...
- ... use of prophylaxis against Pneumocystis carinii pneumonia and antiretroviral ... pneumonia as their initial diagnosis decreased from 62 percent in 1988 to ...
- NLM Digital Collections - Recommendations for evaluating donor eligibility using individual risk-based questions to ...Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, May 2023... Custer B, Quiner C, Haaland R, et al., HIV antiretroviral therapy and prevention use in US blood donors: a new blood safety concern, Blood 2020, 36(11):1351-1358. 44. Grebe E, Di Germanio C, Stone M, et al., HIV incidence in US first-time blood donors during ...
- NLM Digital Collections - The comparative clinical effectiveness and value of simeprevir and sofosbuvir in the ...Publication: [Boston, MA] : Institute for Clinical and Economic Review, April 15, 2014... 000‐ $24,000),119 and even highly active antiretroviral therapy in HIV patients ($1,000‐$79,000).120 ©Institute for ... 000‐ $24,000),119 and even highly active antiretroviral therapy in HIV patients ($1,000‐$79,000).120 ©Institute for ...
- NLM Digital Collections - The Ryan White Program and insurance purchasing in the ACA era : an early look at five statesPublication: Menlo Park, CA : Henry J. Kaiser Family Foundation, April 2015... of the Ryan White Program. Given advances in HIV antiretroviral therapy, Sec. 2616(a) is modified to permit states to "establish a program...to provide therapeutics to treat HIV disease or prevent the serious deterioration of health ...
- ... based, open-arm, randomized clinical trial of combination antiretroviral therapy in advanced HIV disease. Montaner JS, et al. J Acquir Immune ... Brooklyn and Queens, Jamaica, NY 11432, USA.): Proposed antiretroviral ... HIV seroconversion: a practical approach. Infect Control Hosp Epidemiol ...
76 results